FLT4 and carcinoma: The pharmacological effects of lower concentrations of MAZ51 (∼3 μM; an inhibitor of the tyrosine kinase of VEGFR-3) on cell proliferation, migration, and tumor growth in PC-3 cells and a xenograft carcinoma transplantation mouse model were also examined.